Keyphrases
Insulin Resistance
100%
Therapeutic Target
100%
Insulin Signaling Pathway
100%
Personalized Therapy
100%
Type 2 Diabetes Mellitus (T2DM)
60%
Insulin
40%
Polycystic Ovary Syndrome
40%
Age-related
20%
Developing World
20%
Risk Factors
20%
Quality of Life
20%
Insulin Sensitivity
20%
Cellular Response
20%
Obesity
20%
Clinical Phenotype
20%
Disease Progression
20%
Associated Diseases
20%
Lifestyle-related Disease
20%
Non-alcoholic Fatty Liver Disease (NAFLD)
20%
Insulin Sensitizers
20%
Molecular Pathology
20%
Molecular Defects
20%
Novel Therapeutic Targets
20%
Life Expectancy
20%
Therapeutic Approaches
20%
Molecular Diagnostics
20%
Reduced Sensitivity
20%
Current Therapies
20%
Multiple Signalling
20%
Signalling Problem
20%
Molecular Lesions
20%
Resistant Phenotypes
20%
Medicine and Dentistry
Insulin Signaling
100%
Cell Signaling Pathway
100%
Diseases
100%
Maturity Onset Diabetes of the Young
60%
Insulin Resistance
60%
Polycystic Ovarian Syndrome
40%
Signal Transduction
20%
Life Expectancy
20%
Insulin Sensitivity
20%
Disease Exacerbation
20%
Quality of Life
20%
Nonalcoholic Fatty Liver
20%
Insulin Sensitizing Agent
20%
Molecular Diagnosis
20%
Molecular Pathology
20%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Insulin Resistance
60%
Syndrome
60%
Non Insulin Dependent Diabetes Mellitus
60%
Disease Exacerbation
20%
Nonalcoholic Fatty Liver
20%
Insulin Sensitizing Agent
20%
Molecular Pathology
20%
Life Expectancy
20%
Neuroscience
Insulin Signaling
100%
Diabetes Mellitus
100%